Navigation Links
China Medicine Announces Record Fourth Quarter and 2008 Results
Date:3/26/2009

GUANGZHOU, China, March 26 /PRNewswire-Asia / -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a developer and a leading distributor of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional and dietary-supplements, medical devices, and medical formulations in the People's Republic of China ("PRC"), today reported outstanding financial results for the fourth quarter and full year ended December 31, 2008.

    Fourth Quarter 2008 Highlights

    -- Revenues increased 51.2% to $24.4 million
    -- Gross profit increased 30.4% to $5.8 million
    -- Operating income increased 24.5% to $4.2 million
    -- Net income increased 26.6% to $3.5 million
    -- Received approval from the Guangdong Food & Drug Administration
       ("Guangdong FDA") to distribute dental equipment and instruments in
       Guangdong Province
    -- Once again awarded GSP (Good Supply Practice for Pharmaceutical
       Products) certification from State Food and Drug Administration
       (SFDA).
    -- Received rADTZ patent approval for Australia, South Africa and Korea

    Full Year 2008 Highlights

    -- Total revenues increased 27.4% to $53.6 million
    -- Gross profit increased 25.6% to $15.6 million
    -- Operating income increased 30.0% to $11.0 million
    -- Net income increased 32.7% to $9.1 million, or $0.60 per diluted
       share

''We are very pleased with our fourth quarter and full year 2008 results despite the challenging economic environment. In the fourth quarter, revenue increased 51.2% compared to the same period last year. Any slowdown from the global economic crisis was mitigated by expansion of our distribution network and positive seasonal factors in which orders were booked just prior to the end of the year,'' said Mr. Senshan Yang, CEO and Chairman of China Medicine Corporation.

''Ou
'/>"/>

SOURCE China Medicine Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. China Medical Technologies Announces Receipt of SFDA Quality Testing Certificate for its SPR-based Analysis System
2. China Information Security Technology, Inc. Announces that Its Medical Case Statistics Software Selected for Exclusive Contract
3. China Pharma Holdings, Inc. Reports Record 2008 Year End Financial Results and Corporate Updates
4. China Medicine Announces Conference Call to Discuss Fourth and Fiscal Year 2008 Results
5. China Yongxin Pharmaceuticals Inc. Launches Electronic Diagnosis System in its Changchun Drugstores
6. China Nepstar Chain Drugstore Announces Dividend
7. China Sky One Medical to Attend Two Conferences in March
8. China Sky One Medical, Inc. Obtains SFDA Approval for Policresulen Vaginal Suppositories
9. China Pharma Holdings, Inc. to Host Fourth Quarter 2008 Earnings Conference Call at 8:30 a.m. EDT Wednesday March 18, 2009
10. China Yingxia International, Inc.s chairwoman and CEO is in talks with investors in China
11. China Healthcare Acquisition Corp. Announces Stockholder Approval of Charter Amendment to Permit Early Distribution of Its Trust Fund and to Permit Its Continued Existence Without Blank Check Company Provisions and Sets Payment Date
Post Your Comments:
*Name:
*Comment:
*Email: